FIELD: chemistry.
SUBSTANCE: invention concerns peptide compounds representing an amino acid sequence X1KEFX2RIVX3RIKX4FLRX5LVX6, where X1 is N-end segment which is IG; X2 is K or E; X3 is Q or E; X4 is D or R; X5 is N or E; X6 is C-end segment, which is a sequence selected out of PRTE or RPLR; where N-end segment is acetylated and/or C-end segment is amidated; with affinity to toxins, particularly to bacterial toxins, such as lipopolysaccharide or lipoteichoic acid. These compounds can inhibit or neutralise toxins. Invention also concerns pharmaceutical compositions and application of the claimed compounds in prevention or treatment of diseases or states caused by fungi or bacterial infection.
EFFECT: obtaining compounds for prevention or treatment of diseases or states caused by fungi or bacterial infection.
12 cl, 4 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
ANTIMICROBIAL PEPTIDES | 2005 |
|
RU2392962C2 |
ANTIMICROBIAL PEPTIDE | 2014 |
|
RU2695455C2 |
ANTIMICROBIAL PEPTIDE AND USE THEREOF | 2014 |
|
RU2699712C1 |
ANTIBACTERIAL PEPTIDES | 2007 |
|
RU2468033C2 |
ALPHA-MELANOTROPIN PEPTIDE ANALOGUES | 2009 |
|
RU2496786C2 |
MOLECULAR STRUCTURES WITH TARGETING AND EFFECTOR ELEMENTS AND METHODS FOR USE THEREOF | 2016 |
|
RU2703952C2 |
PEPTIDES, DETACHED FROM HUMAN LACTOFERRIN, AND USE THEREOF | 2012 |
|
RU2593757C2 |
NOVEL CELL-PENETRATING PEPTIDES | 2013 |
|
RU2670488C2 |
ANTIBIOTIC PEPTIDES | 2008 |
|
RU2472805C2 |
NEW DERIVATIVES OF SATN2 | 2015 |
|
RU2726124C2 |
Authors
Dates
2009-02-20—Published
2004-01-27—Filed